LAXMI SANKALPA BHAGANAGARAPU and SARUMATHY SUNDARARAJAN 2025. NOVEL APPROACHES FOR ANEMIA IN CARDIORENAL SYNDROME: A RANDOMIZED CONTROLLED TRIAL OF HYPOXIA-INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITOR VS SGLT2 INHIBITOR. Asian Journal of Pharmaceutical and Clinical Research. 18, 12 (Dec. 2025), 184–191. DOI:https://doi.org/10.22159/ajpcr.2025v18i12.57009.